According to world publications, mutations in the SERPINA1 gene may be a genetic risk factor for severe chronic obstructive pulmonary disease and, consequently, rapid progression of respiratory dysfunction. This disease leads to a decrease in the level of alpha-1-antitrypsin protein. It is inherited by autosomal recessive type, but there are registered cases of codominance. In the absence of treatment, diseases of the respiratory system become chronic and lead to disability in adulthood. Early diagnosis of AAT deficiency is important to prevent complications and reduce mortality among people with this pathology. Due to these factors, genetic testing of SERPINA1 gene mutations in children with chronic lung diseases is appropriate to detect a...
Alpha-1 antitrypsin (A1AT or AAT) is a serine protease inhibitor (PI) which, when present at low lev...
Alpha-1 antitrypsin deficiency (AATD), mainly due to the PI*ZZ genotype in SERPINA1, is one of the m...
Rationale: The role of PI (protease inhibitor) type Z heterozygotes and additional rare variant geno...
According to world publications, mutations in the SERPINA1 gene may be a genetic risk factor for sev...
Alpha-1 antitrypsin (AAT) deficiency is an inherited disorder that causes low levels of, or no AAT i...
BACKGROUND: Individuals with severe deficiency in serum alpha(1)-antitrypsin (AAT) concentrations ar...
Background. AAT deficiency is not a rare disease, but one of the most common congenital disorders in...
serum 1-antitrypsin (AAT) concentrations are at high risk for developing chronic obstructive pulmo-n...
Severe alpha1-antitrypsin (AAT) deficiency is a strong risk factor for COPD. But the impact of gene ...
Deficiency in the serine protease inhibitor, alpha-1 antitrypsin (AAT), is known to cause emphysema ...
We report the genetic variants associated with alpha-1 antitrypsin deficiency (AATD) in 117 patients...
Alpha-1 antitrypsin deficiency (AATD) is caused by mutations in the SERPINA1 gene, which encodes the...
Abstract Alpha-1-antitrypsin deficiency (AATD) is a genetic disorder that manifests as pulmonary emp...
Alpha-1 antitrypsin deficiency (AATD) is characterised by deficiency of AAT, the primary inhibitor o...
Background: Alpha-1 antitrypsin (AAT) is a serine protease inhibitor, encoded by the highly polymorp...
Alpha-1 antitrypsin (A1AT or AAT) is a serine protease inhibitor (PI) which, when present at low lev...
Alpha-1 antitrypsin deficiency (AATD), mainly due to the PI*ZZ genotype in SERPINA1, is one of the m...
Rationale: The role of PI (protease inhibitor) type Z heterozygotes and additional rare variant geno...
According to world publications, mutations in the SERPINA1 gene may be a genetic risk factor for sev...
Alpha-1 antitrypsin (AAT) deficiency is an inherited disorder that causes low levels of, or no AAT i...
BACKGROUND: Individuals with severe deficiency in serum alpha(1)-antitrypsin (AAT) concentrations ar...
Background. AAT deficiency is not a rare disease, but one of the most common congenital disorders in...
serum 1-antitrypsin (AAT) concentrations are at high risk for developing chronic obstructive pulmo-n...
Severe alpha1-antitrypsin (AAT) deficiency is a strong risk factor for COPD. But the impact of gene ...
Deficiency in the serine protease inhibitor, alpha-1 antitrypsin (AAT), is known to cause emphysema ...
We report the genetic variants associated with alpha-1 antitrypsin deficiency (AATD) in 117 patients...
Alpha-1 antitrypsin deficiency (AATD) is caused by mutations in the SERPINA1 gene, which encodes the...
Abstract Alpha-1-antitrypsin deficiency (AATD) is a genetic disorder that manifests as pulmonary emp...
Alpha-1 antitrypsin deficiency (AATD) is characterised by deficiency of AAT, the primary inhibitor o...
Background: Alpha-1 antitrypsin (AAT) is a serine protease inhibitor, encoded by the highly polymorp...
Alpha-1 antitrypsin (A1AT or AAT) is a serine protease inhibitor (PI) which, when present at low lev...
Alpha-1 antitrypsin deficiency (AATD), mainly due to the PI*ZZ genotype in SERPINA1, is one of the m...
Rationale: The role of PI (protease inhibitor) type Z heterozygotes and additional rare variant geno...